Hamilton Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hamilton Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,900	Closed	-$287K	–	132
2024 Q3	$287K	Buy	+2,900	New	+$285K	0.07%	77

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Hamilton Wealth's XBI Position: Q4 2024 in Review

Hamilton Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 2,900 shares — an estimated $287K sold.

Hamilton Wealth first reported a position in XBI in Q3 2024 and held it in 1 quarter. The position peaked at $287K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Hamilton Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Hamilton Wealth sold 2,900 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $287K.
Hamilton Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 1 quarter.
Hamilton Wealth's State Street SPDR S&P Biotech ETF position peaked at $287K in Q3 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Hamilton Wealth's 13F filing for Q4 2024, filed 14 Nov 2025.